SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-22-034423
Filing Date
2022-06-23
Accepted
2022-06-22 19:50:45
Documents
15

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 ea161852-posam3_abvcbio.htm   iXBRL POS AM 86308
2 CONSENT OF KCCW ACCOUNTANCY CORP ea161852ex23-2_abvcbio.htm EX-23.2 5524
3 GRAPHIC ex23-1_001.jpg GRAPHIC 3500
  Complete submission text file 0001213900-22-034423.txt   193244

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abvc-20220331.xsd EX-101.SCH 3228
5 XBRL DEFINITION FILE abvc-20220331_def.xml EX-101.DEF 6144
6 XBRL LABEL FILE abvc-20220331_lab.xml EX-101.LAB 10983
7 XBRL PRESENTATION FILE abvc-20220331_pre.xml EX-101.PRE 6014
9 EXTRACTED XBRL INSTANCE DOCUMENT ea161852-posam3_abvcbio_htm.xml XML 2325
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-250899 | Film No.: 221033301
SIC: 2834 Pharmaceutical Preparations